AstraZeneca Loses Bid To Nix Toprol Antitrust Suits

Law360, New York (April 14, 2010, 5:58 PM EDT) -- AstraZeneca Pharmaceuticals LP has lost its bid to toss a pair of consolidated class action complaints filed by Toprol-XL direct purchasers and end-payors accusing the pharmaceutical giant of trying to block generic versions of its blockbuster heart drug through sham patent infringement litigation.

Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware on Tuesday rejected AstraZeneca's motion to dismiss the two antitrust suits for failure to state a claim and denied as moot the drugmaker's request for the court to decline...
To view the full article, register now.